marginally significantP = 0.044
Our sub-group analysis of the definitive RT group indicated that patients treated with high RT doses (≥ 68 Gy) had better long-term progression-free control than those receiving low doses (<68 Gy), and this difference was marginally significant in univariate analysis ( P = 0.044).